Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2012; 18(43): 6255-6262
Published online Nov 21, 2012. doi: 10.3748/wjg.v18.i43.6255
Published online Nov 21, 2012. doi: 10.3748/wjg.v18.i43.6255
Figure 1 Tissue transglutaminase expression in liver tissue specimens from patients.
A: Specimens from patients simultaneously suffering from active celiac disease and primary sclerosing cholangitis; B: Toxic hepatitis; C: Autoimmune hepatitis type I; D: Patient with primary sclerosing cholangitis without celiac disease (CLD); E: Steatosis without CLD; F, G: The basal tissue transglutaminase (tTG) expression in morphologically unaltered liver tissue surrounding colorectal adenocarcinoma metastasis; H: Negative control (no anti-tTG antibody); I: Isotype control (nonspecific mouse Immunoglobulin G1 antibody).
- Citation: Drastich P, Honsová E, Lodererová A, Jarešová M, Pekáriková A, Hoffmanová I, Tučková L, Tlaskalová-Hogenová H, Špičák J, Sánchez D. Celiac disease markers in patients with liver diseases: A single center large scale screening study. World J Gastroenterol 2012; 18(43): 6255-6262
- URL: https://www.wjgnet.com/1007-9327/full/v18/i43/6255.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i43.6255